Login to Your Account



Stepping Stone to China?

Taiwan's Biopharmaceutical Market Capitalization Soars

By Dave Silver
Staff Writer

Wednesday, June 12, 2013
TAIPEI, Taiwan – It's been a long wait, but Taiwan's drug development industry might just be coming of age. While the island nation is still awaiting its first home-grown innovator drug, a number of companies are almost there.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription